Tenon Medical, Inc. Capital Expenditures
Tenon Medical, Inc. (TNON) reported Capital Expenditures of $228.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- Tenon Medical, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $172.00K.
- Tenon Medical, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $56.00K.
- Tenon Medical, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $192.00K.
- Tenon Medical, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was -$111.00K, a 206.73% decline year-over-year.
- Tenon Medical, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $273.00K, a 46.77% increase from fiscal 2024.
- Tenon Medical, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $186.00K, a 48.48% decline from fiscal 2023.
- Tenon Medical, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $361.00K, a 57.38% decline from fiscal 2022.
- Tenon Medical, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $847.00K, a 730.39% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $228.00K 10-Q · filed 2026-08-13 | $420.00K derived: sum of 3 quarters · filed 2026-08-13 | $309.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $56.00K 10-Q · filed 2026-05-15 | $248.00K derived: sum of 2 quarters · filed 2026-05-15 | $137.00K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $81.00K derived: sum of 2 quarters · filed 2026-03-27 | $273.00K 10-K · filed 2026-03-27 | |
| 2025-09-30 | -$111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $81.00K 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $192.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $67.00K derived: sum of 2 quarters · filed 2026-03-27 | $67.00K derived: sum of 3 quarters · filed 2026-03-27 | $186.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $104.00K derived: sum of 2 quarters · filed 2025-11-13 | $223.00K 10-Q · filed 2025-11-13 | $315.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $119.00K 10-Q · filed 2025-08-13 | $211.00K derived: sum of 3 quarters · filed 2025-08-13 | $268.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $119.00K 10-Q · filed 2025-05-13 | $211.00K derived: sum of 2 quarters · filed 2025-05-13 | $268.00K derived: sum of 3 quarters · filed 2025-05-13 | $396.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $149.00K derived: sum of 2 quarters · filed 2025-03-26 | $277.00K derived: sum of 3 quarters · filed 2025-03-26 | $361.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $185.00K derived: sum of 2 quarters · filed 2024-11-14 | $269.00K 10-Q · filed 2024-11-14 | $870.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $212.00K 10-Q · filed 2024-08-13 | $813.00K derived: sum of 3 quarters · filed 2024-08-13 | $890.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $84.00K 10-Q · filed 2023-05-09 | $685.00K derived: sum of 2 quarters · filed 2023-05-09 | $762.00K derived: sum of 3 quarters · filed 2023-11-14 | $803.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | $601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $678.00K derived: sum of 2 quarters · filed 2023-11-14 | $719.00K derived: sum of 3 quarters · filed 2023-11-14 | $847.00K 10-K · filed 2023-03-10 |
| 2022-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $118.00K derived: sum of 2 quarters · filed 2023-11-14 | $246.00K 10-Q · filed 2023-11-14 | $330.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $169.00K 10-Q · filed 2023-08-11 | $253.00K derived: sum of 3 quarters · filed 2023-08-11 | $271.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $128.00K 10-Q · filed 2023-05-09 | $212.00K derived: sum of 2 quarters · filed 2023-05-09 | $230.00K derived: sum of 3 quarters · filed 2023-05-09 | $230.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $102.00K derived: sum of 2 quarters · filed 2023-03-10 | $102.00K derived: sum of 3 quarters · filed 2023-03-10 | $102.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $18.00K derived: sum of 2 quarters · filed 2022-11-10 | $18.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |